ENO1 and Miyoshi myopathy: The protein levels of both 6PGD and ENO1, the glucose consumption levels of glycolytic and PPP intermediates and nucleoside triphosphate (NTP) pools were reduced in multiple haematological cell lines including two MM cell lines after ATX-101 treatment [6].